Condition

Stomach Neoplasms clinical trials and research

• 32Clinical trials
• 2New in 30 days
• 17Countries

Newest Stomach Neoplasms clinical trials

All recruiting trials (32)

• Candonilimab with Fruquintinib and Paclitaxel Albumin-Bound as second-line treatment for advanced gastric cancer

  This phase 2 trial tests whether adding candonilimab to fruquintinib and nab-paclitaxel helps people with advanced gastric or gastroesophageal junction cancer who progressed after first-line therapy.

  Recruiting Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07920224

• TEAS after gastrectomy to aid recovery after laparoscopic stomach cancer surgery

  A randomized trial tests whether transcutaneous electrical acupoint stimulation (TEAS) after laparoscopic gastrectomy helps people recover faster and with less pain compared with a sham treatment.

  Recruiting at 8 sites The Affiliated Hospital of Qingdao University · Qingdao, Shandong and 7 other locations · NCT07898293

• Maintenance therapy in metastatic gastric cancer: a multicenter look from Colombia

  This study reviews medical records of adults with metastatic gastric cancer in Colombia to see how patients fare after starting maintenance therapy following initial chemotherapy.

  Recruiting at 4 sites Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. and 3 other locations · NCT07856212

• Stomach-Partitioning Surgery to Help Block Obstruction in Advanced Stomach Cancer

  This trial tests whether stomach-partitioning gastrojejunostomy helps people with unresectable, advanced stomach cancer better tolerate food after surgery than the standard approach.

  Recruiting Gyeongsang National University Hospital · Changwon, Gyeongsangnam-do · NCT07749326

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• TEAS timing to aid recovery after stomach cancer surgery

  This trial tests whether transcutaneous electrical acupoint stimulation (TEAS) given around surgery helps people recover faster after laparoscopic gastrectomy for gastric cancer.

  Recruiting The Affiliated Hospital of Qingdao University · Dongying, Shandong and 12 other locations · NCT07714980

• Personalized ultrafractionated radiation plus immunotherapy for unresectable stomach cancer

  This study tests, in patients with unresectable locally advanced stomach cancer who have not progressed after initial therapy, whether adding PULSAR radiation to ongoing systemic treatment improves control of the tumor.

  Recruiting Samsung Medical Center · Seoul, Select Province/State · NCT07607119

• Single-port robotic vs traditional laparoscopic surgery for proximal stomach cancer

  This trial tests whether a single-port robotic approach can safely and effectively remove proximal stomach cancer compared with conventional laparoscopy.

  Recruiting First Affiliated Hospital of Wenzhou Medical University · Wenzhou, Zhejiang · NCT07586384

• Spanish SPQUSS-41 questionnaire to measure quality of life after stomach cancer surgery

  We will test whether the Spanish SPQUSS-41 questionnaire accurately measures quality of life in adults who had curative stomach cancer surgery.

  Recruiting at 5 sites Parc de Salut Mar · Badalona, Barcelona and 5 other locations · NCT07504913

• Proximal versus total gastrectomy for locally advanced Siewert type II–III gastroesophageal junction cancer

  This will see if keeping part of the stomach (proximal gastrectomy) or removing the whole stomach (total gastrectomy) leads to better 3-year disease-free survival for adults with locally advanced Siewert type II–III gastroesophageal junction cancer.

  Recruiting Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Istanbul, Istanbul · NCT07482566

• Adebrelimab with famitinib and irinotecan for advanced stomach cancer after first-line treatment stops working

  This trial will try whether adding the immune drug adebrelimab and the targeted drug famitinib to irinotecan helps people with advanced stomach or gastroesophageal junction cancer whose first-line treatment has stopped working.

  Recruiting Phase 2 Shandong Tumor Hospital · Jinan, Shandong · NCT07309185

• LY4337713 for people with FAP-positive ovarian, breast, pancreatic, colorectal, or esophageal cancers

  This trial tests LY4337713, a FAP-targeted lutetium-177 therapy, in people with advanced cancers that show high levels of fibroblast activation protein (FAP).

  Recruiting at 17 sites Phase 1 Eli Lilly and Company · Newport Beach, California and 29 other locations · NCT07213791

• Comparing argon plasma coagulation and endoscopic mucosal resection for small gastric adenomas

  This trial will test whether argon plasma coagulation or endoscopic mucosal resection works better to treat small (≤1 cm) gastric adenomas with low-grade dysplasia.

  Recruiting at 3 sites Samsung Medical Center · Goyang-si and 2 other locations · NCT07161479

• LY4257496 for GRPR-positive advanced breast, colorectal, prostate, and endometrial cancer (OMNIRAY)

  This Phase 1 test tries LY4257496, with GRPR imaging using LY4257529 and sometimes standard treatments, to see if it is safe and helps people with GRPR-positive advanced breast, colorectal, prostate, or endometrial cancer.

  Recruiting at 15 sites Phase 1 Eli Lilly and Company · Duarte, California and 32 other locations · NCT07114601

• High-sensitivity blood test to detect and monitor multiple cancers

  This study will test a high-sensitivity blood test that looks for tumor DNA to detect and follow several common cancers in adults with those cancers or people having routine health screenings.

  Recruiting Yonsei University · Seoul · NCT07035587

• Conversion therapy with surgery and targeted para‑aortic radiotherapy for gastric cancer with retroperitoneal (station 16) lymph node spread

  This trial tests whether chemotherapy (SOX with or without a PD‑1 inhibitor), followed by D2 gastrectomy and para‑aortic radiotherapy, helps people with gastric adenocarcinoma who have only para‑aortic lymph node metastases live longer without their cancer progressing compared with standard chemotherapy alone.

  Recruiting Phase 2 Shandong Cancer Hospital and Institute · Jinan, Shandong · NCT07007182

• Anti-mesothelin TNhYP218 CAR T cell therapy for mesothelin-expressing solid tumors

  This treatment will test whether a person's own engineered CAR T cells that target mesothelin can help adults with mesothelin-expressing solid tumors, including mesothelioma, that have returned or spread after standard therapy.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06885697

• Perioperative HER2-targeted therapy plus chemotherapy for locally advanced unresectable stomach or gastroesophageal junction cancer

  This Phase 2 trial tests giving trastuzumab deruxtecan with capecitabine (and rilvegostomig) before and after surgery for adults with HER2-positive, locally advanced unresectable stomach or GEJ cancer to try to shrink tumors so they can be removed and lower the chance of recurrence.

  Recruiting Phase 2 Samsung Medical Center · Seoul · NCT06630130

• Evaluating a new treatment for HER2-positive gastric cancer

  This study is testing a new treatment called IAH0968 combined with a standard chemotherapy for people with advanced HER2-positive gastric cancer to see if it works better than the usual treatment.

  Recruiting at 2 sites Phase 2/3 SUNHO（China）BioPharmaceutical CO., Ltd. · Harbin, Heilongjiang and 1 other locations · NCT06504732

• Combining immunotherapy and chemotherapy for advanced gastric cancer

  This study is testing if combining a new immune treatment with chemotherapy can help people with advanced gastric cancer feel better and improve their chances of recovery.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT06451211

• Testing a new drug for adults with advanced solid tumors

  This study is testing a new drug for adults with advanced solid tumors that haven't responded to other treatments to see if it can help them.

  Recruiting at 43 sites Phase 1 Seagen Inc. · Phoenix, Arizona and 47 other locations · NCT06131840

• Evaluating HTL0039732 for Advanced Solid Tumours

  This study is testing a new drug called HTL0039732, alone and with another treatment, to see if it can help people with advanced solid tumors by boosting their immune response against cancer.

  Recruiting at 6 sites Phase 1/2 Cancer Research UK · Cambridge and 5 other locations · NCT05944237

• Robotic surgery for early gastric cancer using a new technique

  This study is testing a new robotic surgery technique for early stomach cancer to see if it can help patients recover better and have fewer problems after surgery compared to the usual method.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT05892289

• Imaging solid tumors using a new tracer called 68Ga-FAPI

  This study is testing a new imaging method using a special tracer to see if it can help doctors better detect certain types of cancer in patients who are having surgery.

  Recruiting Phase 1 Karolinska University Hospital · Stockholm · NCT05172310

• Combining PD-1 blockade with chemotherapy for gastric cancer treatment

  This study is testing if a new combination of a cancer drug and chemotherapy can help people with advanced stomach cancer respond better to treatment before and after surgery.

  Recruiting at 2 sites Phase 2 Shenzhen People's Hospital · Shenzhen, Guangdong and 1 other locations · NCT05033392

• Helicobacter pylori and stomach cancer in the French West Indies

  This project will test how common Helicobacter pylori infection is in adults newly diagnosed with stomach cancer in Martinique.

  Recruiting University Hospital Center of Martinique · Fort-de-France · NCT04949737

• Pooling clinical experiences of patients treated with Lutetium-177 in Spain

  This study looks at how well Lutetium-177 works and how safe it is for patients with certain types of tumors in Spain by collecting information from their medical records.

  Recruiting at 11 sites Sociedad Española de Medicina Nuclear e Imagen Molecular · Santiago de Compostela, A Coruña and 19 other locations · NCT04949282

• Endoscopic biopsy versus surgical specimen for molecular and pathology testing in stomach cancer

  This study will see if tissue taken by endoscopy gives the same pathology and molecular marker results as the tissue removed at surgery for adults with gastric cancer.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT04809025

• Comparing laparoscopic and open surgery for advanced stomach cancer

  This study is testing whether laparoscopic surgery is better than open surgery for people with advanced stomach cancer in terms of recovery and long-term health outcomes.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT04710758

• Testing a new drug for advanced solid tumors

  This study is testing a new drug called sigvotatug vedotin to see if it can safely help people with advanced solid tumors, both on its own and with other treatments.

  Recruiting at 145 sites Phase 1 Seagen Inc. · Anchorage, Alaska and 157 other locations · NCT04389632

• Database of patients with cardia cancer at Institut Paoli-Calmettes

  This study is collecting information from patients with cardia cancer to help improve understanding and treatment for this type of cancer in the future.

  Recruiting Institut Paoli-Calmettes · Marseille, Bouches-du Rhône · NCT02869477

• Collecting samples and studying the natural history of malignant mesothelioma

  This study is collecting tissue samples from people with malignant mesothelioma and certain other cancers to learn more about the disease and help improve future treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT01950572

Related topics

Quick answers

How many Stomach Neoplasms clinical trials are recruiting right now?

32, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 17 countries. The most sites are in China (15 trials), United States (6 trials), South Korea (6 trials), Spain (5 trials), France (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 6, Phase 2: 6, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →